These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 9257833)
21. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones. Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821 [TBL] [Abstract][Full Text] [Related]
22. MHC and T cell development. Viret C; Janeway CA Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575 [TBL] [Abstract][Full Text] [Related]
23. Defined alphabeta T cell receptors with distinct ligand specificities do not require those ligands to signal double negative thymocyte differentiation. Erman B; Guinter TI; Singer A J Exp Med; 2004 Jun; 199(12):1719-24. PubMed ID: 15210747 [TBL] [Abstract][Full Text] [Related]
24. Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor. Beddoe T; Chen Z; Clements CS; Ely LK; Bushell SR; Vivian JP; Kjer-Nielsen L; Pang SS; Dunstone MA; Liu YC; Macdonald WA; Perugini MA; Wilce MC; Burrows SR; Purcell AW; Tiganis T; Bottomley SP; McCluskey J; Rossjohn J Immunity; 2009 Jun; 30(6):777-88. PubMed ID: 19464197 [TBL] [Abstract][Full Text] [Related]
25. TCR vaccines against T cell lymphoma: QS-21 and IL-12 adjuvants induce a protective CD8+ T cell response. Wong CP; Okada CY; Levy R J Immunol; 1999 Feb; 162(4):2251-8. PubMed ID: 9973501 [TBL] [Abstract][Full Text] [Related]
26. Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding. Willcox BE; Gao GF; Wyer JR; O'Callaghan CA; Boulter JM; Jones EY; van der Merwe PA; Bell JI; Jakobsen BK Protein Sci; 1999 Nov; 8(11):2418-23. PubMed ID: 10595544 [TBL] [Abstract][Full Text] [Related]
27. Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-gamma production in vitro. Szczepanik M; Anderson LR; Ushio H; Ptak W; Owen MJ; Hayday AC; Askenase PW J Exp Med; 1996 Dec; 184(6):2129-39. PubMed ID: 8976169 [TBL] [Abstract][Full Text] [Related]
28. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition. Vollmer J; Weltzien HU; Moulon C J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014 [TBL] [Abstract][Full Text] [Related]
30. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. Matsuda H; Ushio H; Geba GP; Askenase PW J Immunol; 1997 Mar; 158(6):2891-7. PubMed ID: 9058826 [TBL] [Abstract][Full Text] [Related]
31. The interchain disulfide linkage of T-cell antigen receptor-alpha and -beta chains is a prerequisite for T-cell activation. Li Z; Wu W; Kemp O; Stephen M; Manolios N Cell Immunol; 1998 Dec; 190(2):101-11. PubMed ID: 9878111 [TBL] [Abstract][Full Text] [Related]
32. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex. Rubin B; Riond J; Leghait J; Gairin JE Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695 [TBL] [Abstract][Full Text] [Related]
33. Recombinant adenovirus vaccine encoding a chimeric T-cell antigen receptor induces protective immunity against a T-cell lymphoma. Wong CP; Levy R Cancer Res; 2000 May; 60(10):2689-95. PubMed ID: 10825142 [TBL] [Abstract][Full Text] [Related]
34. TCR vaccines for active immunotherapy of T cell malignancies. Okada CY; Wong CP; Denney DW; Levy R J Immunol; 1997 Dec; 159(11):5516-27. PubMed ID: 9548492 [TBL] [Abstract][Full Text] [Related]
35. The binding affinity of a soluble TCR-Fc fusion protein is significantly improved by crosslinkage with an anti-Cβ antibody. Ozawa T; Horii M; Kobayashi E; Jin A; Kishi H; Muraguchi A Biochem Biophys Res Commun; 2012 Jun; 422(2):245-9. PubMed ID: 22575452 [TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant. Nakano T; Ishii Y; Ishizaka K J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020 [TBL] [Abstract][Full Text] [Related]
37. Gamma/delta T cells from tolerized alpha/beta-TCR-deficient mice antigen specifically inhibit contact sensitivity in vivo and IFN-gamma production in vitro. Szczepanik M; Anderson LR; Ushio H; Ptak W; Owen MJ; Hayday AC; Askenase PW Int Arch Allergy Immunol; 1997; 113(1-3):373-5. PubMed ID: 9130583 [TBL] [Abstract][Full Text] [Related]
38. Epicutaneous immunization with protein antigen in the presence of TLR4 ligand induces TCR alpha beta+CD4+ T contrasuppressor cells that reverse skin-induced suppression of Th1-mediated contact sensitivity. Ptak W; Majewska M; Bryniarski K; Ptak M; Lobo FM; Zajac K; Askenase PW; Szczepanik M J Immunol; 2009 Jan; 182(2):837-50. PubMed ID: 19124727 [TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain. Xavier RM; Nakamura M; Tsunematsu T J Immunol; 1994 Mar; 152(5):2624-32. PubMed ID: 8133068 [TBL] [Abstract][Full Text] [Related]
40. Soluble T cell receptors: detection and quantitative assay in fluid phase via ELISA or immuno-PCR. Sperl J; Paliwal V; Ramabhadran R; Nowak B; Askenase PW J Immunol Methods; 1995 Oct; 186(2):181-94. PubMed ID: 7594618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]